Qingsong Health (02661) has announced that its board of directors passed a resolution to exercise the share repurchase authorization on June 22, 2026.
Under this authorization, the company may repurchase its issued shares on the open market with a maximum value of HK$100 million, effective from the date of this announcement until the conclusion of the forthcoming annual general meeting of shareholders.
The company anticipates that the repurchases under this share buyback authorization will be funded using surplus cash from its balance sheet.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments